{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:40:05Z","timestamp":1792464005890,"version":"4.5.0"},"reference-count":57,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Given the significant burden that diabetes self\u2010management poses, it is important to assess patient\u2010reported outcomes (PROs) for Type 2 diabetes (T2D) treatments in clinical trials and real\u2010world studies. Complex insulin regimens are associated with increased risk of hypoglycaemia and body weight gain, which could negatively impact treatment adherence and, therefore, achievement of glycaemic targets. iGlarLixi is a once\u2010daily fixed\u2010ratio combination of insulin glargine 100\u2009U\/mL and the glucagon\u2010like peptide\u20101 receptor agonist (GLP\u20101 RA), lixisenatide. iGlarLixi is an effective treatment alternative to complex insulin regimens, with a favourable between\u2010group difference in body weight and reduced risk of hypoglycaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is the first review to summarise data from multiple validated PRO measures for recent iGlarLixi studies (Soli\u2010CGM, SoliMix, Soli\u2010SWITCH, IDEAL, SUCCESS and SIMPLIFY JP), including: Global Treatment Effectiveness Evaluation, Audit of Diabetes Dependent Quality of Life, Diabetes Medication Satisfaction Tool, Diabetes Therapy\u2010Related Quality of Life, Diabetes Treatment Satisfaction Questionnaire, Hypoglycaemic Attitudes and Behaviour Scale and Treatment\u2010Related Impact Measure Diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In clinical studies, once\u2010daily iGlarLixi was associated with numerical improvements in selected treatment satisfaction measures in those who switched from: complex insulin regimens (once\u2010 or twice\u2010daily premixed insulin and basal\u2010bolus insulin), basal insulin or oral glucose\u2010lowering medications. Additionally, in real\u2010world studies, iGlarLixi was generally associated with improvements in treatment satisfaction and quality of life outcomes in adults with T2D who previously received basal\u2010bolus insulin or oral glucose\u2010lowering medications\u2009\u00b1\u2009basal insulin or GLP\u20101 RAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, a once\u2010daily injection of iGlarLixi may offer a clinically beneficial, simplified treatment option for adults with T2D compared with complex insulin\u2010based regimens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.71436","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:14:08Z","timestamp":1792462448000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient\u2010Reported Outcomes Following Initiation or Simplification of Treatment With\n                    <scp>iGlarLixi<\/scp>\n                    in Adults With Type 2 Diabetes: A Narrative Review"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-2678","authenticated-orcid":false,"given":"Francesco","family":"Giorgino","sequence":"first","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases University of Bari Aldo Moro  Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-6888","authenticated-orcid":false,"given":"Martin","family":"Haluz\u00edk","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine (IKEM)  Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Sanofi  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Lauand","sequence":"additional","affiliation":[{"name":"Sanofi  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie Corp dit","family":"Genti","sequence":"additional","affiliation":[{"name":"Sanofi  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir H.","family":"Assaad\u2010Khalil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Unit of Diabetes, Lipidology and Metabolism, Faculty of Medicine Alexandria University  Alexandria Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Thacker","sequence":"additional","affiliation":[{"name":"Bhatia Hospital  Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases Jagiellonian University Medical College  Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguzhan","family":"Deyneli","sequence":"additional","affiliation":[{"name":"Ko\u00e7 University Hospital  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-3275","authenticated-orcid":false,"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"1","key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/dom.15471","article-title":"Person\u2010Reported Outcomes in Diabetes Care: What Are They and Why Are They So Important?","volume":"26","author":"Hermanns N.","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"e_1_2_12_3_1","unstructured":"D.Silva \u201cHelping Measure Person\u2010Centred Care: A Review of Evidence About Commonly Used Approaches and Tools to Help Measure Person\u2010Centred Care \u201d(2014) The Health Foundation March."},{"key":"e_1_2_12_4_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Johnston B. C. P. D.","year":"2024"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-008-9396-4"},{"issue":"3","key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/S2589-7500(22)00249-7","article-title":"The Role of Patient\u2010Reported Outcome Measures in Trials of Artificial Intelligence Health Technologies: A Systematic Evaluation of ClinicalTrials.Gov Records (1997\u20132022)","volume":"5","author":"Pearce F. J.","year":"2023","journal-title":"Lancet Digital Health"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S156279"},{"issue":"1","key":"e_1_2_12_8_1","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for Industry: Patient\u2010Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims: Draft Guidance","volume":"4","author":"U. S. Department of Health and Human Services, F. D. A. Center for Drug Evaluation Research","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15332"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21903"},{"issue":"1","key":"e_1_2_12_11_1","first-page":"S183","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2025","journal-title":"Diabetes Care"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S301"},{"issue":"1","key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12902-015-0044-z","article-title":"Geographic Patterns in Patient Demographics and Insulin Use in 18 Countries, a Global Perspective From the Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy (MOSAIc)","volume":"15","author":"Polinski J. M.","year":"2015","journal-title":"BMC Endocrine Disorders"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05078-3"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/PPA.S123389","article-title":"Insulin Adherence and Persistence Among Chinese Patients With Type 2 Diabetes: A Retrospective Database Analysis","volume":"11","author":"He X.","year":"2017","journal-title":"Patient Preference and Adherence"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1348"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.12.014"},{"issue":"10","key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.clinthera.2015.08.004","article-title":"Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States","volume":"37","author":"Eby E. L.","year":"2015","journal-title":"Clinical Therapeutics"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-022-01222-2"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.02.001"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0868-9"},{"key":"e_1_2_12_22_1","unstructured":"Food and Drug Administration \u201cSoliqua Prescribing Information \u201d(2019) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/208673s002lbl.pdf."},{"key":"e_1_2_12_23_1","unstructured":"Food and Drug Administration \u201cXultophy Prescribing Information \u201d(2016) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208583s000lbl.pdf."},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1357"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0917"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1495"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15724"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0393"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16276"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70362"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13851"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14822"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01645-z"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01435-z"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15599"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16214"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696990701478856"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026485130100"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624070-00006"},{"key":"e_1_2_12_40_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-015-1782-8","article-title":"Diabetes\u2010Dependent Quality of Life (ADDQOL) and Affecting Factors in Patients With Diabetes Mellitus Type 2 in Greece","volume":"8","author":"Papazafiropoulou A. K.","year":"2015","journal-title":"BMC Research Notes"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16251"},{"issue":"1","key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2337\/dc08-0856","article-title":"Diabetes Medication Satisfaction Tool: A Focus on Treatment Regimens","volume":"32","author":"Anderson R. T.","year":"2009","journal-title":"Diabetes Care"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.665111"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.3.530"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-57"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.08.002"},{"issue":"9","key":"e_1_2_12_47_1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11136-011-9886-7","article-title":"Examining the Ability to Detect Change Using the TRIM\u2010Diabetes and TRIM\u2010Diabetes Device Measures","volume":"20","author":"Brod M.","year":"2011","journal-title":"Quality of Life Research"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000685"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1925"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1836"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-191"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S24752"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0167"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13132"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03605.x"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0117.x"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.29.3.166"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71436","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.71436","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:14:11Z","timestamp":1792462451000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.71436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":57,"alternative-id":["10.1111\/dom.71436"],"URL":"https:\/\/doi.org\/10.1111\/dom.71436","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"2026-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"dom.71436"}}